RLC Global Forum and Hamat Celebrate Industry Leadership at the 2026 RLC Honors in Riyadh 12-02-2026, 16:21

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound 9-07-2024, 07:00

World Stroke Organization and Philips call for action to expand access to life-saving stroke care 10-09-2024, 20:00